However, later studies indicated that PD-1 expression on peripheral blood leukocytes may provide a more useful and practical indicator of cancer progression, and may assist in identifying patients likely to respond to PD-1/PD-L1 blockade [23, 24]. The gene discussed is PDCD1; the disease is cancer.